03:06:45 EDT Mon 27 May 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Z:QGEN - QIAGEN NV - http://www.qiagen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
QGEN - Z0.139.37·48.270.143.73+0.571.3614.126,2544,34743.76  43.85  43.5549.1754  35.8145May 24May 1415 min RT 2¢

Recent Trades - Last 10 of 4347
Time ETExPriceChangeVolume
17:36:49Z45.5952.42510
16:40:30Z43.730.56430
16:01:21Z43.730.561,559
16:01:17Z43.730.56680
16:01:03Z43.730.56723
16:00:14Z43.730.5648
16:00:14Z43.730.565,700
16:00:14Z43.730.5660
16:00:13Z43.730.561,300
16:00:13Z43.730.56769

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-14 16:05U:QGENNews ReleaseQIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
2024-05-13 02:00U:QGENNews ReleaseQIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results
2024-05-07 16:05U:QGENNews ReleaseQIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
2024-05-02 16:05U:QGENNews ReleaseQIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
2024-04-29 16:05U:QGENNews ReleaseQIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
2024-04-24 16:05U:QGENNews ReleaseQIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
2024-04-09 09:49U:QGENNews ReleaseQIAGEN N.V. to release results for Q1 2024 and hold webcast
2024-04-03 16:05U:QGENNews ReleaseQIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
2024-03-25 16:05U:QGENNews ReleaseQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
2024-03-18 16:05U:QGENNews ReleaseQIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
2024-03-11 06:00U:QGENNews ReleaseQIAGEN announces Form 20-F annual report filing for 2023 results
2024-02-27 17:45U:QGENNews ReleaseQIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
2024-02-27 16:05U:QGENNews ReleaseQIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
2024-02-15 16:05U:QGENNews ReleaseQIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
2024-02-06 16:05U:QGENNews ReleaseQIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
2024-01-25 10:00U:QGENNews ReleaseQIAGEN announces partnership with Penn State University to advance microbiome sciences
2024-01-18 16:05U:QGENNews ReleaseQIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million
2024-01-11 07:54U:QGENNews ReleaseQIAGEN N.V. to release results for Q4 2023 and hold webcast
2024-01-08 02:00U:QGENNews ReleaseQIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
2024-01-07 13:07U:QGENNews ReleaseQIAGEN announces plans to return approximately $300 million to shareholders